My response to an old long starting to reestablish
Post# of 2022
IMO no need to be concerned as much as in the past about dilution despite warnings by the perennial bears who stalk this cave and refuse to move to another den. The last 2 lab investments show a new understanding to dilution and the value EVIO is bringing to the table. With a new CFO and experienced Fortune 500 personal added with stock induced compensation believe me they have the full understanding of shareholders and the expectations. Enjoy the ride.
PS Not to say dilution should not be a concern but as long as we are moving forward getting major stakes in targeted high growth areas with all necessary licensing I see little concern.
PSS You did notice that Keystone partners did a private deal for almost 1.3 Mil shares of EVIO stock for $1.19 a share. This is huge as in reality with the amount paid by EVIO for 50% was $500K + 1.3 Mil shares licensed and going legal.
Follow the money.